Retrospective analysis reveals gene fusions as prognostic biomarkers in advanced melanoma, suggesting novel therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Nibeyro et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: